ask why

Latest research

Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.

Psychiatry · JAMA Psychiatry · 2026-09-01

Network meta-analysis of 95 RCTs (5898 antipsychotic-treated patients with schizophrenia spectrum disorders): vs placebo, semaglutide (−10.98 kg), liraglutide (−5.43 kg), topiramate, metformin and exenatide were associated with the largest weight loss (moderate certainty).

Meta-analysisn = 5,898
Stogios et al. Pharmacological Interventions for Weight Reduction in Patients With Schizophrenia Treated With Antipsychotics: A Systematic Review and Network Meta-Analysis
Public health and primary care · PLoS Med · 2025-12-08

In 240 participants with hyperandrogenic PCOS and BMI 25-48 randomised to low-dose COCPs, metformin or both for 24 weeks, metabolic syndrome prevalence did not differ (28.8%, 26.2%, 28.6%; p=0.26); diarrhoea was common with metformin.

RCTn = 240
Dokras et al. Impact of combined hormonal contraceptives and metformin on metabolic syndrome in women with hyperandrogenic polycystic ovary syndrome and obesity: The COMET-PCOS randomized clinical trial

Sign in to react

Enter your email and we send a 6-digit code and a link. No password.

Your name and role

These appear beside any methods concern you post and on your profile page.